Literature DB >> 20145142

Comment re: Premenopausal mammographic density and hormone levels.

Pagona Lagiou, Dimitrios Trichopoulos, Chung-Cheng Hsieh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145142      PMCID: PMC2875181          DOI: 10.1158/0008-5472.CAN-09-3311

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Ethnicity affects IGFBP-3 and IGF-II in normal healthy young adult subjects.

Authors:  K D Hopkins; E D Lehmann; R L Jones; J M Holly; S C Cwyfan-Hughes; R C Turay; J D Teale; R G Gosling
Journal:  Clin Endocrinol (Oxf)       Date:  1996-09       Impact factor: 3.478

2.  Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.

Authors:  Henning Grønbaek; Allan Flyvbjerg; Lene Mellemkjaer; Anne Tjønneland; Jane Christensen; Henrik Toft Sørensen; Kim Overvad
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-11       Impact factor: 4.254

3.  Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women.

Authors:  Valerie A McCormack; Mitch Dowsett; Elizabeth Folkerd; Nichola Johnson; Claire Palles; Ben Coupland; Jeff M Holly; Sarah J Vinnicombe; Nicholas M Perry; Isabel dos Santos Silva
Journal:  Breast Cancer Res       Date:  2009-06-22       Impact factor: 6.466

4.  The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.

Authors:  Isabel dos Santos Silva; Nichola Johnson; Bianca De Stavola; Gabriela Torres-Mejía; Olivia Fletcher; Diane S Allen; Naomi E Allen; Timothy J Key; Ian S Fentiman; Jeff M P Holly; Julian Peto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

5.  A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk.

Authors:  N E Allen; A W Roddam; D S Allen; I S Fentiman; I Dos Santos Silva; J Peto; J M P Holly; T J Key
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.